Condensed Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net loss	$ (43,000)	$ (128,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	46,000	45,000
Amortization of deferred finance and debt discount	59,000	164,000
Provision for bad debts	0	4,000
Provision for slow moving and obsolete inventory	42,000	42,000
Share-based payment expense	36,000	18,000
Changes in:
Accounts receivable	(48,000)	(49,000)
Inventory	93,000	(144,000)
Prepaid expenses and other current assets	19,000	(11,000)
Accounts payable	3,000	98,000
Accrued expenses and other current liabilities	(6,000)	(2,000)
Wages payable	(16,000)	54,000
Net cash provided by operating activities	185,000	91,000
Cash flows from investing activities:
Purchase of property, plant and equipment	0	(4,000)
Patent application costs	(6,000)	(3,000)
Net cash (used in) investing activities	(6,000)	(7,000)
Cash flows from financing activities:
Proceeds (payments) on debt financing	(75,000)	(1,070,000)
Proceeds from refinance	0	1,200,000
Deferred finance costs	0	(130,000)
Proceeds from lines of credit	3,095,000	3,483,000
Payments on lines of credit	(3,179,000)	(3,486,000)
Net cash (used in) financing activities	(159,000)	(3,000)
Net Increase / (decrease) in cash and cash equivalents	20,000	81,000
Cash and cash equivalents - beginning of period	158,000	352,000
Cash and cash equivalents - end of period	178,000	433,000
Supplemental disclosures of cash flow information
Cash paid during period for interest	79,000	131,000
Cash paid during period for taxes	1,000	0
Consulting expense prepaid with restricted stock	49,000	0
Debt issuance cost paid with restricted stock	$ 96,000	$ 0